Douglas Lane & Associates, LLC Pfizer Inc Transaction History

Douglas Lane & Associates, LLC

$7.1 Billion
Q3 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 37,569 shares of PFE stock, worth $963,644. This represents 0.02% of its overall portfolio holdings.

Number of Shares

37,569

Previous 43,211 13.06%

Holding current value

$963,644

Previous $1.21 Million 10.09%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$27.7 - $31.39 $156,283 - $177,102	-5,642 Reduced 13.06%	37,569 $1.09 Million
Q2 2024 Jul 08, 2024	SELL	$25.26 - $29.6 $87,551 - $102,593	-3,466 Reduced 7.43%	43,211 $1.21 Million
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $18,226 - $20,929	704 Added 1.53%	46,677 $1.3 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $77,579 - $100,767	-2,969 Reduced 6.07%	45,973 $1.32 Million
Q3 2023 Oct 16, 2023	BUY	$32.09 - $37.51 $75,828 - $88,636	2,363 Added 5.07%	48,942 $1.62 Million
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $20,516 - $23,736	-568 Reduced 1.2%	46,579 $1.71 Million
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $50,497 - $65,740	1,282 Added 2.8%	47,147 $1.92 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $24,340 - $31,773	-583 Reduced 1.26%	45,865 $2.35 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $21,710 - $28,340	-520 Reduced 1.11%	46,448 $2.38 Million
Q3 2022 Oct 14, 2022	BUY	$43.76 - $53.42 $36,845 - $44,979	842 Added 1.83%	46,968 $2.06 Million
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $57,418 - $68,079	1,234 Added 2.75%	46,126 $2.42 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $24,567 - $30,442	537 Added 1.21%	44,892 $2.32 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $11,280 - $16,721	-273 Reduced 0.61%	44,355 $2.62 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $96,947 - $124,537	-2,470 Reduced 5.24%	44,628 $1.92 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $35,048 - $39,703	976 Added 2.12%	47,098 $1.84 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $163,464 - $184,355	-4,881 Reduced 9.57%	46,122 $1.67 Million
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $35,545 - $45,198	-1,062 Reduced 2.04%	51,003 $1.88 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $22,034 - $25,851	-694 Reduced 1.32%	52,065 $1.91 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $146,835 - $178,132	-4,875 Reduced 8.46%	52,759 $1.73 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $79,954 - $114,237	-2,958 Reduced 4.88%	57,634 $1.88 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $70,152 - $79,614	-2,131 Reduced 3.4%	60,592 $2.37 Million
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $42,431 - $55,021	-1,306 Reduced 2.04%	62,723 $2.25 Million
Q2 2019 Jul 08, 2019	SELL	$36.98 - $41.52 $14,163 - $15,902	-383 Reduced 0.59%	64,029 $2.77 Million
Q1 2019 Apr 23, 2019	BUY	$37.5 - $41.2 $26,475 - $29,087	706 Added 1.11%	64,412 $2.74 Million
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $75,555 - $86,141	-1,964 Reduced 2.99%	63,706 $2.78 Million
Q3 2018 Oct 09, 2018	BUY	$34.47 - $41.81 $61,735 - $74,881	1,791 Added 2.8%	65,670 $2.89 Million
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $38,817 - $41,383	-1,177 Reduced 1.81%	63,879 $2.32 Million
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $193,183 - $224,119	-6,054 Reduced 8.51%	65,056 $2.31 Million
Q4 2017 Jan 24, 2018	SELL	$33.26 - $35.29 $130,113 - $138,054	-3,912 Reduced 5.21%	71,110 $2.58 Million
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $2.33 Million - $2.56 Million	75,022	75,022 $2.68 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Pfizer Inc Transaction History